--- title: "LanzaTech Global | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 9.279 B" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/266626907.md" datetime: "2025-11-19T22:24:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/266626907.md) - [en](https://longbridge.com/en/news/266626907.md) - [zh-HK](https://longbridge.com/zh-HK/news/266626907.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/266626907.md) | [English](https://longbridge.com/en/news/266626907.md) # LanzaTech Global | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 9.279 B Revenue: As of FY2025 Q3, the actual value is USD 9.279 B, beating the estimate of USD 10.2 M. EPS: As of FY2025 Q3, the actual value is USD 0.99, beating the estimate of USD -12.42. EBIT: As of FY2025 Q3, the actual value is USD -15.97 B. ### Financial Metrics by Segment #### Revenue - **Total Revenue**: $9.3 million for the three months ended September 30, 2025, compared to $9.9 million for the same period in 2024, representing a decrease of 7%. - **Total Revenue**: $27.8 million for the nine months ended September 30, 2025, compared to $37.6 million for the same period in 2024, representing a decrease of 26%. #### Cost of Revenue - **Cost of Revenue**: $6.9 million for the three months ended September 30, 2025, compared to $8.1 million for the same period in 2024, representing a decrease of 15%. - **Cost of Revenue**: $20.7 million for the nine months ended September 30, 2025, compared to $20.4 million for the same period in 2024, representing an increase of 1%. #### Operating Expenses - **Research and Development (R&D) Expense**: $10.3 million for the three months ended September 30, 2025, compared to $22.0 million for the same period in 2024, representing a decrease of 53%. - **R&D Expense**: $41.7 million for the nine months ended September 30, 2025, compared to $60.5 million for the same period in 2024, representing a decrease of 31%. - **Selling, General and Administrative (SG&A) Expense**: $6.7 million for the three months ended September 30, 2025, compared to $11.5 million for the same period in 2024, representing a decrease of 41%. - **SG&A Expense**: $41.6 million for the nine months ended September 30, 2025, compared to $34.2 million for the same period in 2024, representing an increase of 21%. #### Other Income (Expense) - **Other Income (Expense), Net**: $18.7 million for the three months ended September 30, 2025, compared to - $18.9 million for the same period in 2024, representing an increase of 199%. - **Other Income (Expense), Net**: $40.1 million for the nine months ended September 30, 2025, compared to - $20.9 million for the same period in 2024, representing an increase of 292%. #### Net Income (Loss) - **Net Income (Loss)**: $2.9 million for the three months ended September 30, 2025, compared to - $57.4 million for the same period in 2024, representing an increase of 105%. - **Net Income (Loss)**: - $48.9 million for the nine months ended September 30, 2025, compared to - $110.7 million for the same period in 2024, representing an increase of 56%. #### Cash Flow - **Net Cash Used in Operating Activities**: - $58.7 million for the nine months ended September 30, 2025, compared to - $69.4 million for the same period in 2024, representing a decrease of 15%. - **Net Cash Provided by Investing Activities**: $11.4 million for the nine months ended September 30, 2025, compared to $14.1 million for the same period in 2024, representing a decrease of 19%. - **Net Cash Provided by Financing Activities**: $25.6 million for the nine months ended September 30, 2025, compared to $40.2 million for the same period in 2024, representing a decrease of 36%. ### Future Outlook and Strategy #### Core Business Focus - **Strategic Actions**: LanzaTech is focusing on streamlining its business priorities, taking actions to reduce its cost structure, and evaluating other liquidity-enhancing initiatives, including pursuing capital raising, partnership or asset-related opportunities, and other strategic options. - **Cohort-Based Operating Model**: LanzaTech introduced a cohort-based operating model to guide the phased deployment of commercial projects, aiming to systematically de-risk execution, align resources and capital allocation, and build revenue visibility as each cohort advances into operations. #### Non-Core Business - **Government Shutdown Risk**: The company acknowledges the risk of delays in critical DOE-dependent project milestones in the event of a prolonged federal government shutdown, which could shift expected revenue recognition from project services, equipment sales, or offtake-linked products. #### Priority - **Financing**: Obtaining additional financing, including an Other Financing, remains essential to LanzaTech’s efforts to continue operations and execute its business plan. ### 相關股票 - [LanzaTech Global (LNZA.US)](https://longbridge.com/zh-HK/quote/LNZA.US.md) ## 相關資訊與研究 - [AngioDynamics Q3 revenue beats estimates on Med Tech strength, raises outlook](https://longbridge.com/zh-HK/news/281504186.md) - [Nike Takes 'Intentional' Hit To Clear 'Unhealthy Inventory' In Q3 As CEO Eyes Turnaround By Year-End](https://longbridge.com/zh-HK/news/281362844.md) - [Nike Delivers Q3 Earnings Beat As Turnaround Progresses, Shares Slide](https://longbridge.com/zh-HK/news/281243092.md) - [Nike Q3 revenue flat, net income down 35% but beats estimates amid turnaround](https://longbridge.com/zh-HK/news/281239071.md) - [MSC Industrial Q2 sales rise 2.9% but miss estimates](https://longbridge.com/zh-HK/news/281350153.md)